Thank you for the great video Cameron,.How do you determine the excess cash when it is not as easy as seeing an amount in the balance sheet under "Short term investment" ? In this video you kept 1B$ for operating their business and the rest was attributed to excess cash. Is there a process to determine the amount and be conservative?
Hi Cameron. Interesting take. I've been watching Zoetis for a while but it's never gone down to a price I feel comfortable buying. A lot of the stocks want to buy, like LVMH, CE, and ASML, have strong moats but are too expensive...
I am interested in CE as well..what is your fair value? The problem i see there could be the high price spent for the M&M acquisition that could not bring the desired results
@@derekwelbeck9327 same situation and price as me..i think 90 is good and in the previous down i must admit i was a bit too emotional and didnt enter..let's see if there will be a second chance!
Very interesting! Terry Smith brings up a great point on how pet insurance and care is going to be a staple in the future as society changes, curious to see how this will perform in the long term.
Great video andf great company! I was lucky to pick it up in november at 129. Now wondering if it has gone up too fast and I should secure gains or follow my strategy and hold. What is your opinion on this kind of dilemma Cameron? If you keep kicking out your quality holdings just because they go up I guess you end up missing out on the whole idea of compounding? Cameron: You are brilliant at explaining how to decide on buying - how about some reflection on when to sell for instance if a good quality company go up like ZTS.
When estimating the Market Cap ten years from now, why do we take the Enterprise Value from 2032, but the current Debt and Cash? If we see Debt growing by 9% per year, wouldn't it be fair to assume that ten years from now the Debt will be higher than today's levels? That would spillover in a lower price estimate and give different IRR estimates
@@ibrahimciftci9599 I worry whether in Zoetis' case it may be 'diworsification'. For example, the pharma products segment from zoetis is a tough, competitive industry to remain dominant in long term due to patents rolling off. The moats in pharma are weaker than in their other segments. Their other businesses like selling lab services to vets seem to have the most durable competitive advantages.
As always great video Cameron. You might want to take a look at POOL corp. Strong moat, consistent revenue and free cashflow growth, a 20 year track record of share buybacks and dividends and currently the cheapest it has been for the last 10 years on a P/E basis.
Hi Cameron, would you mind analyzing Medifast (MED)?
Thank you for the great video Cameron,.How do you determine the excess cash when it is not as easy as seeing an amount in the balance sheet under "Short term investment" ? In this video you kept 1B$ for operating their business and the rest was attributed to excess cash. Is there a process to determine the amount and be conservative?
Hi Cameron. Interesting take. I've been watching Zoetis for a while but it's never gone down to a price I feel comfortable buying. A lot of the stocks want to buy, like LVMH, CE, and ASML, have strong moats but are too expensive...
I am interested in CE as well..what is your fair value? The problem i see there could be the high price spent for the M&M acquisition that could not bring the desired results
@@fabriziob7664 I'd be comfortable buying it at 90. It went to that price last year but I didn't buy.
@@derekwelbeck9327 same situation and price as me..i think 90 is good and in the previous down i must admit i was a bit too emotional and didnt enter..let's see if there will be a second chance!
Read Terry Smith on Pe ratios. You could have payed 40x PE and still overperformed with these companies
Nice Job Wood you do Canadian national railway Plees ?
Very interesting! Terry Smith brings up a great point on how pet insurance and care is going to be a staple in the future as society changes, curious to see how this will perform in the long term.
Thanks for sharing, was it in his book ?
It was from one of his online lectures. I believe it was the one in regards to traits of a quality company, something along those lines
Great Video. Would love to hear your take on British American tobacco (BTI)
He already did it. Check the channel
Nice overview!
Great video andf great company! I was lucky to pick it up in november at 129. Now wondering if it has gone up too fast and I should secure gains or follow my strategy and hold. What is your opinion on this kind of dilemma Cameron? If you keep kicking out your quality holdings just because they go up I guess you end up missing out on the whole idea of compounding? Cameron: You are brilliant at explaining how to decide on buying - how about some reflection on when to sell for instance if a good quality company go up like ZTS.
Let the winners run 🏃♂️
Thank you very much.
Would be interesting to hear your analysis of HDSN.
Best wishes.
Also, they pay a very rapidly growing dividend. Not much of a yield right now, but the dividend growth rate is amazing if they can keep it up.
Thank you for this analyze! Again, great work Cameron and your team. What about TMO?
Another great video Cameron, thank you!
Old Dominion Freight Please! :)
Fertilizer companies are also looking interesting
Always hoping to see that trifecta t-shirt.
When estimating the Market Cap ten years from now, why do we take the Enterprise Value from 2032, but the current Debt and Cash? If we see Debt growing by 9% per year, wouldn't it be fair to assume that ten years from now the Debt will be higher than today's levels? That would spillover in a lower price estimate and give different IRR estimates
Great analysis as usual
Updates on big tech or pharmaceuticals would be interesting
yeah quite a few of pharma companies look somewhat cheap right now
Idexx is very similar to Zoetis. I would love a comparison as I have always felt Idexx was actually higher quality.
Zoetis is more diversified
@@ibrahimciftci9599 I worry whether in Zoetis' case it may be 'diworsification'.
For example, the pharma products segment from zoetis is a tough, competitive industry to remain dominant in long term due to patents rolling off. The moats in pharma are weaker than in their other segments. Their other businesses like selling lab services to vets seem to have the most durable competitive advantages.
@@Ljcoleslaw could be but it’s kind of a monopoly anyways with huge pricing power ( both have pricing power )
Can you please do video on BAC?
Greate video! Thx! Could you run your analysis for Levi's (NYSE:LEVI)?
Nice video, Trulieve update?
Any update on this stock mate?
Good company. I haven’t looked at the numbers recently
Nice, thanks!
I'll never.
As always great video Cameron. You might want to take a look at POOL corp. Strong moat, consistent revenue and free cashflow growth, a 20 year track record of share buybacks and dividends and currently the cheapest it has been for the last 10 years on a P/E basis.
A good company
medpace MEDP please